74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
DaVita Inc
Closed
SectorHealthcare
139.63 0.37
Overview
Share price change
24h
Min
137.16
Max
140.56
Income | 135M 349M |
|---|---|
Sales | 35M 3.3B |
P/E Sector Avg | 12.442 57.333 |
EPS | 2.24 |
Profit margin | 10.6 |
Employees | 76,000 |
EBITDA | 8.4M 727M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +23.24% upside |
Next Earnings | 1 May 2025 |
|---|
Market Cap | -3.3B 11B |
|---|---|
Previous open | 139.26 |
Previous close | 139.63 |
Technical Score
By Trading Central
Confidence
Bearish Evidence
DaVita Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
DaVita Inc Forecast
Price Target
By TipRanks
23.24% upside
12 Months Forecast
Average 172 USD 23.24%
High 184 USD
Low 165 USD
Based on 4 Wall Street analysts offering 12 month price targets forDaVita Inc - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About DaVita Inc
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
